FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2047353241> ?p ?o ?g. }

• W2047353241 abstract "Medications to control intraocular pressure (IOP) are frequently preserved using benzalkonium chloride (BAK), which can negatively affect the ocular surface. Data are needed to assess efficacy and safety of prostaglandin drugs preserved with and without BAK. The present study compared the efficacy and safety of BAK-free travoprost 0.004% (TRAV) and BAK 0.02%–preserved bimatoprost 0.01% (BIM) during late-day time points in patients with open-angle glaucoma or ocular hypertension. This was a 12-week, phase 4, randomized, investigator-masked, crossover study. 84 patients with IOP ≥24 and <36 mmHg were randomized 1:1 to receive once-daily TRAV or BIM for 6 weeks followed by an additional 6-week crossover period. IOP was measured at the end of each treatment period at 4, 6, and 8 pm. TRAV was considered noninferior to BIM if the upper limit of the 95% CI of the between-group difference in mean IOP was ≤1.5 mmHg. Adverse events were assessed throughout the study. One patient discontinued due to allergic conjunctivitis, and 2 patients with missing data were excluded; 81 patients were included in the per-protocol population (mean ± SD age, 58.3 ± 11.4 years; TRAV/BIM, n = 41; BIM/TRAV, n = 40). After 6 weeks, mean IOP with TRAV (17.4 ± 2.7 mmHg; change from baseline, -6.0 mmHg) was similar to BIM (17.2 ± 2.6 mmHg; change from baseline, -6.3 mmHg); the between-group difference was 0.22 mmHg (95% CI, -0.22 to 0.67). Thus, noninferiority of TRAV versus BIM was demonstrated. Mean IOP at each time point and mean and percentage IOP change from baseline were not significantly different between treatments. All treatment-emergent adverse events were mild to moderate. The incidences of mild ocular hyperemia with TRAV and BIM were 31% and 39%, respectively; moderate hyperemia was observed in 2% of patients receiving BIM. Late-day IOP-lowering efficacy of BAK-free TRAV was noninferior to that of BAK 0.02%–preserved BIM; both reduced baseline IOP by 25%. Both treatments were well tolerated, although a higher incidence of moderate ocular hyperemia was observed with BIM. ClinicalTrials.gov identifier, NCT01464424 ; registered November 1, 2011." @default.
• W2047353241 created "2016-06-24" @default.
• W2047353241 creator A5001322214 @default.
• W2047353241 creator A5029077792 @default.
• W2047353241 date "2014-11-28" @default.
• W2047353241 modified "2023-10-18" @default.
• W2047353241 title "Late-day intraocular pressure–lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial" @default.
• W2047353241 cites W1968292175 @default.
• W2047353241 cites W1972009235 @default.
• W2047353241 cites W1973886676 @default.
• W2047353241 cites W1981229680 @default.
• W2047353241 cites W1988164713 @default.
• W2047353241 cites W1993188304 @default.
• W2047353241 cites W1994970293 @default.
• W2047353241 cites W2001256953 @default.
• W2047353241 cites W2002127297 @default.
• W2047353241 cites W2022185097 @default.
• W2047353241 cites W2030745953 @default.
• W2047353241 cites W2043769051 @default.
• W2047353241 cites W2043835167 @default.
• W2047353241 cites W2048902780 @default.
• W2047353241 cites W2064230716 @default.
• W2047353241 cites W2072814044 @default.
• W2047353241 cites W2086321796 @default.
• W2047353241 cites W2090251911 @default.
• W2047353241 cites W2110897487 @default.
• W2047353241 cites W2121349793 @default.
• W2047353241 cites W2135654921 @default.
• W2047353241 cites W2140594570 @default.
• W2047353241 cites W2141570579 @default.
• W2047353241 cites W2162316179 @default.
• W2047353241 cites W2169539793 @default.
• W2047353241 cites W2408099444 @default.
• W2047353241 cites W2625521663 @default.
• W2047353241 cites W4237700722 @default.
• W2047353241 cites W84625781 @default.
• W2047353241 doi "https://doi.org/10.1186/1471-2415-14-151" @default.
• W2047353241 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4298043" @default.
• W2047353241 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25432143" @default.
• W2047353241 hasPublicationYear "2014" @default.
• W2047353241 type Work @default.
• W2047353241 sameAs 2047353241 @default.
• W2047353241 citedByCount "8" @default.
• W2047353241 countsByYear W20473532412016 @default.
• W2047353241 countsByYear W20473532412017 @default.
• W2047353241 countsByYear W20473532412021 @default.
• W2047353241 countsByYear W20473532412022 @default.
• W2047353241 countsByYear W20473532412023 @default.
• W2047353241 crossrefType "journal-article" @default.
• W2047353241 hasAuthorship W2047353241A5001322214 @default.
• W2047353241 hasAuthorship W2047353241A5029077792 @default.
• W2047353241 hasBestOaLocation W20473532411 @default.
• W2047353241 hasConcept C118487528 @default.
• W2047353241 hasConcept C126322002 @default.
• W2047353241 hasConcept C142724271 @default.
• W2047353241 hasConcept C168563851 @default.
• W2047353241 hasConcept C197934379 @default.
• W2047353241 hasConcept C204787440 @default.
• W2047353241 hasConcept C27081682 @default.
• W2047353241 hasConcept C2775919038 @default.
• W2047353241 hasConcept C2776521421 @default.
• W2047353241 hasConcept C2776740260 @default.
• W2047353241 hasConcept C2777336333 @default.
• W2047353241 hasConcept C2778375690 @default.
• W2047353241 hasConcept C2778527774 @default.
• W2047353241 hasConcept C2779526769 @default.
• W2047353241 hasConcept C2780276452 @default.
• W2047353241 hasConcept C2781092963 @default.
• W2047353241 hasConcept C2908647359 @default.
• W2047353241 hasConcept C71924100 @default.
• W2047353241 hasConcept C87813604 @default.
• W2047353241 hasConcept C99454951 @default.
• W2047353241 hasConceptScore W2047353241C118487528 @default.
• W2047353241 hasConceptScore W2047353241C126322002 @default.
• W2047353241 hasConceptScore W2047353241C142724271 @default.
• W2047353241 hasConceptScore W2047353241C168563851 @default.
• W2047353241 hasConceptScore W2047353241C197934379 @default.
• W2047353241 hasConceptScore W2047353241C204787440 @default.
• W2047353241 hasConceptScore W2047353241C27081682 @default.
• W2047353241 hasConceptScore W2047353241C2775919038 @default.
• W2047353241 hasConceptScore W2047353241C2776521421 @default.
• W2047353241 hasConceptScore W2047353241C2776740260 @default.
• W2047353241 hasConceptScore W2047353241C2777336333 @default.
• W2047353241 hasConceptScore W2047353241C2778375690 @default.
• W2047353241 hasConceptScore W2047353241C2778527774 @default.
• W2047353241 hasConceptScore W2047353241C2779526769 @default.
• W2047353241 hasConceptScore W2047353241C2780276452 @default.
• W2047353241 hasConceptScore W2047353241C2781092963 @default.
• W2047353241 hasConceptScore W2047353241C2908647359 @default.
• W2047353241 hasConceptScore W2047353241C71924100 @default.
• W2047353241 hasConceptScore W2047353241C87813604 @default.
• W2047353241 hasConceptScore W2047353241C99454951 @default.
• W2047353241 hasIssue "1" @default.
• W2047353241 hasLocation W20473532411 @default.
• W2047353241 hasLocation W20473532412 @default.
• W2047353241 hasLocation W20473532413 @default.
• W2047353241 hasLocation W20473532414 @default.
• W2047353241 hasOpenAccess W2047353241 @default.
• W2047353241 hasPrimaryLocation W20473532411 @default.
• W2047353241 hasRelatedWork W1557598834 @default.

• next